EDIT Competitors & Alternatives
Compare Editas Medicine Inc with similar stocks in the same industry
Biotechnology
EDIT
Main Stock$1.91
-12.21%
Tradestie Score
51
Market Cap
$319.22M
Revenue Growth
37.4%
Analyst Upside
+220.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 7/10
Genomics Precision Med
Crispr Gene Editing
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.09
-9.64%
|
$371.64M | - | 50 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$8.47
-11.12%
|
$357.51M | - | 28 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.42
-4.27%
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$9.72
-5.45%
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.85
-0.37%
|
$353.70M | - | 36 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.59
-8.55%
|
$332.96M | - | 46 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.54
-1.60%
|
$328.62M | - | 26 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.46
-8.47%
|
$307.12M | - | 32 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$6.13
-1.21%
|
$304.12M | - | 47 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.34
-4.96%
|
$297.23M | - | 36 | Compare |
More EDIT Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry